Private label (PL) has had a few good turns over the past several years. The    economy helped drive growth as people looked to save money in the recession. The massive recalls of J&J adult and kid’s products (Tylenol, Benadryl, Motrin), and less so for Novartis (Excedrin) allowed PL to dominate store shelves when brands were [...]

read more: What’s Happening with Private Label in OTC?